Lentiviral Vectors Approach the Clinic but Fall Back: National Institutes of Health Recombinant DNA Advisory Committee Review of a First Clinical Protocol for Use of a Lentiviral Vector

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular therapy 2001-10, Vol.4 (4), p.282-283
1. Verfasser:	Podsakoff, Greg M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - genetics Acquired Immunodeficiency Syndrome - therapy Advisory Committees Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Clinical Trials as Topic - methods Clinical Trials as Topic - standards Consent DNA, Recombinant - adverse effects DNA, Recombinant - therapeutic use Gene therapy Genetic Therapy - methods Genetic Therapy - standards Genetic Vectors - genetics HIV Human immunodeficiency virus Humans Infections Lentivirus - genetics Lymphocytes National Institutes of Health (U.S.) Patient safety United States Vectors (Biology)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!